Evidence map›Paper›PMID 34224090›Full record

ArticleJournal of nephrology2022

Long-term health-related quality of life outcomes of adults with pediatric onset of frequently relapsing or steroid-dependent nephrotic syndrome.

Marie-Sophie Meuleman, Sophie Guilmin-Crépon, Aurélie Hummel, Eric Daugas, Agnès Dumas, Fallou Leye, Jacques Dantal, Claire Rigothier, François Provot, Dominique Chauveau and 22 more

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of nephrology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Podocytopathies.Nature reviews. Disease primers · 2025
    Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors at 18 institutions in 1 country.

Marie-Sophie MeulemanService de Néphrologie et Transplantation, Centre de Référence Maladie Rare "Syndrome Néphrotique Idiopathique", Assistance Publique des Hôpitaux de Paris (AP-HP), Hôpitaux Universitaires Henri Mondor, Fédération Hospitalo-Universitaire "Innovative Therapy for Immune Disorders", 51 Avenue du Marechal-de-Lattre-de-Tassigny, Créteil Cedex, 94010, Creteil, France. marie.meuleman@aphp.fr.
Sophie Guilmin-CréponUniversité de Paris, ECEVE UMR 1123, INSERM, 75010, Paris, France.
Aurélie HummelService de Néphrologie, AP-HP, Hôpital Necker, Paris, France.
Eric DaugasService de Néphrologie, AP-HP, Hôpital Bichat, Université de Paris, INSERM U1149, Paris, France.
Agnès DumasUniversité de Paris, ECEVE UMR 1123, INSERM, 75010, Paris, France.
Fallou LeyeUnité d'Épidémiologie Clinique, CIC 1426, AP-HP.Nord, Hôpital Universitaire Robert Debré, Inserm, 75019, Paris, France.
Jacques DantalService de Néphrologie Immunologie Clinique Transplantation, Centre de Recherche en Transplantation et Immunologie (CRTI), Centre Hospitalier Universitaire (CHU) de Nantes, Nantes, France.
Claire RigothierService de Néphrologie Transplantation, Dialyse et Aphérèses, CHU de Bordeaux, Bordeaux, France.
François ProvotService de Néphrologie, Hôpital Huriez, CHU de Lille, Lille, France.
Dominique ChauveauService de Néphrologie et Transplantation d'Organes, Hôpital de Rangueil et Centre de Référence Maladies Rénales Rares, CHU de Toulouse, Toulouse, France.
Stéphane BurteyAPHM, INSERM, INRAe, C2VN, Centre de Néphrologie et Transplantation Rénale, Hôpital de la Conception, Aix Marseille University, Marseille, France.
Alexandre HertigService de Néphrologie et Transplantation Rénale, AP-HP, Hôpital Tenon, Paris, France.
Karine DahanService de Néphrologie et Dialyse, AP-HP, Hôpital Tenon, Paris, France.
Antoine DurrbachService de Néphrologie et Transplantation, Centre de Référence Maladie Rare "Syndrome Néphrotique Idiopathique", Assistance Publique des Hôpitaux de Paris (AP-HP), Hôpitaux Universitaires Henri Mondor, Fédération Hospitalo-Universitaire "Innovative Therapy for Immune Disorders", 51 Avenue du Marechal-de-Lattre-de-Tassigny, Créteil Cedex, 94010, Creteil, France.
Claire DossierService de Néphrologie Pédiatrique, AP-HP, Hôpital Robert Debré, Paris, France.
Alexandre KarrasService de Néphrologie, AP-HP, Hôpital Européen Georges Pompidou, Université de Paris, Paris, France.
Dominique GuerrotService de Néphrologie, CHU de Rouen, Rouen, France.
Vincent EsnaultService de Néphrologie, Hôpital Pasteur, CHU de Nice, Nice, France.
Philippe RémyService de Néphrologie et Transplantation, Centre de Référence Maladie Rare "Syndrome Néphrotique Idiopathique", Assistance Publique des Hôpitaux de Paris (AP-HP), Hôpitaux Universitaires Henri Mondor, Fédération Hospitalo-Universitaire "Innovative Therapy for Immune Disorders", 51 Avenue du Marechal-de-Lattre-de-Tassigny, Créteil Cedex, 94010, Creteil, France.
Ziad A MassyService de Néphrologie, AP-HP, Hôpital Ambroise Paré, Boulogne-Billancourt, France.
Isabelle TostivintService de Néphrologie et Transplantation, AP-HP, Hôpital Pitié Salpêtrière, Paris, France.
Marie-Pascale MorinService de Néphrologie, Hôpital de Pontchaillou, CHU de Rennes, Rennes, France.
Philippe ZaouiService de Néphrologie, Hémodialyse, Aphérèse et Transplantation Rénale, CHU de Grenoble Alpes, Université Grenoble-Alpes, Grenoble, France.
Olivier FritzService de Néphrologie, Centre Hospitalier (CH) La Rochelle, La Rochelle, France.
Moglie Le QuintrecService de Néphrologie Dialyse et Transplantation Rénale, Hôpital Lapeyronie, CHU de Montpellier, Montpellier, France.
Alain WynckelService de Néphrologie, CHU de Reims, Reims, France.
Aurélie BourmaudUniversité de Paris, ECEVE UMR 1123, INSERM, 75010, Paris, France.
Olivia BoyerService de Néphrologie Pédiatrique, Centre de Référence Maladie Rare "Syndrome Néphrotique Idiopathique", Institut Imagine, AP-HP, Hôpital Necker-Enfants Malades, Université de Paris, Paris, France.
Dil SahaliService de Néphrologie et Transplantation, Centre de Référence Maladie Rare "Syndrome Néphrotique Idiopathique", Assistance Publique des Hôpitaux de Paris (AP-HP), Hôpitaux Universitaires Henri Mondor, Fédération Hospitalo-Universitaire "Innovative Therapy for Immune Disorders", 51 Avenue du Marechal-de-Lattre-de-Tassigny, Créteil Cedex, 94010, Creteil, France.
Corinne AlbertiUniversité de Paris, ECEVE UMR 1123, INSERM, 75010, Paris, France.
Vincent Audard *Service de Néphrologie et Transplantation, Centre de Référence Maladie Rare "Syndrome Néphrotique Idiopathique", Assistance Publique des Hôpitaux de Paris (AP-HP), Hôpitaux Universitaires Henri Mondor, Fédération Hospitalo-Universitaire "Innovative Therapy for Immune Disorders", 51 Avenue du Marechal-de-Lattre-de-Tassigny, Créteil Cedex, 94010, Creteil, France.
Hélène Mellerio *Université de Paris, ECEVE UMR 1123, INSERM, 75010, Paris, France.
Inserm · FRSorbonne Université · FRAssistance Publique – Hôpitaux de Paris · FRCentre Hospitalier Universitaire Henri-Mondor · FRHôpital Necker-Enfants Malades · FRCentre Hospitalier de La Rochelle · FRCentre Hospitalier Universitaire de Bordeaux · FRCentre Hospitalier Universitaire de Grenoble · FRCentre Hospitalier Universitaire de Lille · FRCentre Hospitalier Universitaire de Montpellier · FRCentre Hospitalier Universitaire de Nantes · FRCentre Hospitalier Universitaire de Nice · FRCentre Hospitalier Universitaire de Reims · FRCentre Hospitalier Universitaire de Rouen · FRCentre Hospitalier Universitaire de Toulouse · FRHôpital Pontchaillou · FRUniversité Claude Bernard Lyon 1 · FRUniversité Paris Cité · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLong-term psychosocial outcomes and health-related quality of life (HRQOL) in adults with pediatric onset of frequently relapsing or steroid-dependent idiopathic nephrotic syndrome (FRNS or SDNS) remain to be determined.

methodsIn this prospective cohort study, 59 adults with pediatric onset of FRNS/SDNS and persistent active glomerular disease in adulthood completed the GEDEPAC-2 questionnaire exploring 11 well-being domains. Data were compared to the French general population (FGP) with standardized incidence ratio ([SIR]; adjusted for period, age, gender). Regression models were performed to identify predictive factors of psychosocial well-being.

resultsIn 82% of cases, the questionnaire was completed while the participants (n = 59; 47 men; median age = 32 years; median number of relapses = 13) were in complete remission (under specific therapy in 76% of cases). Participants had higher educational degree than in the FGP (SIR = 6.3; p < 0.01) and more frequently a managerial occupation (SIR = 3.1; p < 0.01). Social integration was acceptable with regard to marital status and experience of sexual intercourse, but experiences of discrimination were far more frequent (SIR = 12.5; p < 0.01). The SF-12 mental component summary (MCS) score was altered (Z-score = - 0.6; p < 0.01) and mean multidimensional fatigue inventory (MFI-20) global fatigue score appeared high (12). Transfer from pediatric to adult healthcare was followed by a period of discontinued care for 33% of participants. Multivariate analysis revealed a close relationship between MFI-20, physical health, and MCS.

conclusionsThis study shows that pediatric onset FRNS and SDNS may have a long-term negative impact on mental HRQOL and highlights the impact of fatigue, which is often not adequately considered in routine care.

Indexed as

Nephrotic SyndromeAdultChildFatigueFemaleHumansImmunosuppressive AgentsMaleProspective StudiesQuality of LifeRecurrenceSteroidsImmunosuppressive AgentsSteroidsEducationFamily lifeIdiopathic nephrotic syndromeLong-term outcomesQuality of lifeSocioprofessional status

Identifiers

PMID34224090
OpenAlexW3178375760

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.